Mikel, Charles C. http://orcid.org/0000-0002-3040-073X
Goldfarb, David S.
Ponte, Amy http://orcid.org/0000-0003-3023-357X
Steigelman, Katherine http://orcid.org/0000-0002-2237-2118
Latyshev, Sergey http://orcid.org/0000-0003-4050-4863
Funding for this research was provided by:
Nightmaker Science, LLC
Travere Therapeutics, Inc
Article History
Received: 29 July 2022
Accepted: 22 September 2022
First Online: 6 October 2022
Declarations
:
: CM: Employee of Nightmaker Science, LLC DG: Research funding, Travere; Owner, Moonstone Nutrition Inc. AP: Current employee and stockholder of Travere Therapeutics, Inc. KS: Current employee and stockholder of Travere Therapeutics, Inc. SL: Employee of Nightmaker Science, LLC.
: The data used for the analyses in this manuscript are available on request from Travere Therapeutics, Inc., San Diego, CA.
: Patient samples were de-identified and consent was obtained prior to collection.
: Travere Therapeutics, Inc, provided financial and material support for the research and, with the assistance of study investigators, monitored the conduct of the study, collected data from the investigative centers, and analyzed the data. Travere Therapeutics, Inc, also consulted with advisors and study investigators on the study design and assisted the authors in preparation and review of the manuscript. Travere Therapeutics, Inc, provided funding for professional medical writing and editorial assistance to MedVal Scientific Information Services, Princeton, NJ.